Approval · Notice of Compliance 36297 · 2025
COMBOGESIC: Notice of Compliance 36297
Issued October 31, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36297
- Date
- October 31, 2025
- Company
- Aft Pharmaceuticals (Can) LimitedToronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMBOGESIC | 02488280 | Marketed |
Medicinal ingredients
- ACETAMINOPHEN 325 MG per TAB
- IBUPROFEN 97.5 MG per TAB